Photo of Dr. Hagop Kantarjian from obroncology.com
May 19, 2024, 10:00
Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph+ ALL
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X:
“A comprehensive review of the research history and current status of ponatinib in CML and Ph+ ALL
Elias Jabbour of MD Anderson Comprehensive Cancer Center.”
Source: Hagop Kantarjian/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19